Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Justification for type of information:
endpoint for information only

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report date:
2012

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 436 (Acute Inhalation Toxicity: Acute Toxic Class Method)
Deviations:
no
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Reference substance name:
stannous oxalate
IUPAC Name:
stannous oxalate

Test animals

Species:
rat
Strain:
other: HsdHan:WIST strain
Sex:
male/female

Administration / exposure

Route of administration:
inhalation: dust
Type of inhalation exposure:
nose only
Vehicle:
air
Analytical verification of test atmosphere concentrations:
yes
Duration of exposure:
4 h
Concentrations:
5, 1, 0.5 mg/L
No. of animals per sex per dose:
6
Control animals:
no

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
male/female
Dose descriptor:
LC50
Effect level:
2 mg/L air
Based on:
test mat.
Remarks:
dust
Exp. duration:
4 h
Remarks on result:
other: calculated LC50 in accordance with OECD 436
Sex:
male/female
Dose descriptor:
LC0
Effect level:
0.5 mg/L air
Based on:
test mat.
Remarks:
dust
Exp. duration:
4 h
Remarks on result:
other: at the dose of 0.5 mg/L no mortality was observed
Remarks:
.
Mortality:
All animals treated at a concentration of 5 mg/L died or were killed in extremis. Two males and one female treated at a concentration of 1 mg/L died or were killed in extremis. All animals exposed to a concentration of 0.5 mg/L survived treatment.
Body weight:
All surviving rats showed a loss in body weight during the first week of the observation period. However, all surviving rats gained weight during the second week of the observation period. All surviving rats, except for two females exposed to a concentration of 1 mg/L had reached their pre-exposure body weight by Day 15.
Gross pathology:
Abnormalities noted at necropsy of animals that that died or were killed in extremis during the study were red, dark, mottled or inflated lungs, pale or dark areas on the lungs, gaseous distension of the stomach, red nasal cavity, white substance in the nasal cavity and small and red thymus. No abnormalities were noted at necropsy of animals killed at the end of the study period except for pale or dark foci on the lungs noted in one female treated at a concentration of 0.5 mg/L.

Applicant's summary and conclusion

Interpretation of results:
other: Category 4 based on EU GHS criteria
Conclusions:
The test material was classified as Category 4 in respect of its acute inhalation toxicity according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS).